Literature DB >> 17177328

[Construction and expression of recombinant adenovirus expression vector of beta-defensin-2].

Zhuo Shi1, Qiang Shu, Zheng-yan Zhao.   

Abstract

OBJECTIVE: To explore the possibility of stable expression of cationic peptide beta-defensin-2 in eukaryocytes with adenovirus vector.
METHODS: The rat beta-defensin-2 (rBD2) gene was cloned at the downstream of CMV promoter of the adenoviral shuttle plasmid pShuttle-CMV. Then pShuttle-CMV-rBD2 was transformed into E. coli BJ5183-AD-1, in which recombination occurred between plasmids and pAdEasy-1 to construct pAdEasy-rBD2. After confirmation by endonuclease, linear pAdEasy-rBD2 was transformed into 292 cells to obtain packaged adenoviral expression vector, which was used to infect cos-7 cells and to establish respiratory adenovirus infection model of rat. The in vivo and in vitro expression activity of recombinant adenovirus was detected by Western blot and immunohistochemistry. RESULT: The inserted DNA of pShuttle-CMV-rBD2 consisted of rat beta-defensin-2 gene. The pathological effect of infected cells, electronic microscopic observation and PCR showed that the recombinant adenovirus vector was constructed successfully. The concentration of the adenovirus was 10(9) PFU/ml. The vector expressed rat beta-defensin-2 efficiently in vivo and in vitro.
CONCLUSION: The recombinant adenovirus vector can express cationic peptide beta-defensin-2 in eukaryocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177328     DOI: 10.3785/j.issn.1008-9292.2006.06.003

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  1 in total

1.  A novel technique for the preparation of (125)I-5-trimethylstannyl-1-(2-deoxy-2-fluoro-beta-D-arabino-furanosyl) uracil [correction of urail] and its biodistribution pattern in Kunming mice.

Authors:  Jia Hu; Yongxue Zhang; Xun Sun; Duolan Li; Chongjiao Li; Chunxia Qin; Wei Cao; Xiaoli Lan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.